• DMXAA (Vadimezan): Advanced Workflows in Cancer Biology Rese

  2026-06-18

  DMXAA (Vadimezan) stands at the forefront of applied cancer biology as a potent vascular disrupting agent and STING agonist. This guide details optimized protocols, novel nanomedicine use-cases, and practical troubleshooting for maximizing DMXAA’s impact in tumor immunity and vascular disruption studies.

• TAI-1 Hec1 Inhibitor: Precision Mitotic Control in Cancer Mo

  2026-06-18

  Explore how TAI-1, a potent Hec1 inhibitor, uniquely enables high-fidelity mitotic disruption and apoptotic cell death induction in advanced cancer research. This article delivers a deeper mechanistic analysis and practical guidance for leveraging TAI-1 in translational oncology.

• MMP-2/MMP-9-Mediated BBB Disruption in Arsenic Neurotoxicity

  2026-06-17

  A recent study demonstrates that sodium arsenite exposure impairs cognition in male mice by upregulating MMP-2 and MMP-9, causing blood-brain barrier (BBB) breakdown and neuronal apoptosis. Use of the matrix metalloproteinases inhibitor doxycycline hyclate preserved BBB integrity and mitigated cognitive deficits, providing mechanistic insight and translational direction for neurovascular research.

• Erastin as a Ferroptosis Inducer: Optimizing Cancer & Neurob

  2026-06-17

  Erastin unlocks precise, reproducible ferroptosis induction for cancer and neurodegeneration studies, targeting RAS-mutant tumor cells and neuronal models alike. This guide details optimized workflows, actionable troubleshooting, and new cross-domain insights anchored in recent neurobiology breakthroughs.

• Rhodamine B as a Tracer: Shaping Next-Gen Environmental Risk

  2026-06-16

  Explore how Rhodamine B (Basic Violet 10) is redefining quantitative tracing for translational researchers, bridging mechanistic insight with field-scale validation, and providing strategic guidance for complex environmental and biological workflows. This article uniquely synthesizes mechanistic foundations, experimental best practices, and the regulatory outlook, moving beyond typical product pages to frame Rhodamine B’s evolving role in agricultural and environmental risk assessment.

• Caffeine (1,3,7-trimethylpurine-2,6-dione): Lab Evidence & L

  2026-06-16

  Caffeine (1,3,7-trimethylpurine-2,6-dione) is a purine alkaloid with well-documented roles as an adenosine receptor antagonist and metabolic modulator. This article details its quantitative effects on cancer cell lines, energy metabolism, and translational research workflows, clarifying practical limits and protocol essentials.

• Canagliflozin Hemihydrate: Protocols and Troubleshooting in

  2026-06-15

  Canagliflozin hemihydrate, a research-grade SGLT2 inhibitor from APExBIO, enables precision studies of renal glucose reabsorption and metabolic pathways. This article details experimental workflows, critical troubleshooting, and cross-validates assay specificity using recent mTOR pathway screening advances.

• Triazole ALDH2 Activators: Enhanced Cardiac Protection in MI

  2026-06-15

  The reference study introduces a new class of triazole-based ALDH2 activators with markedly improved water solubility and enzymatic activation, leading to significant reduction in myocardial infarct size and improved cardiac function in mice. These findings advance the field of myocardial ischemia treatment, especially for populations with genetically reduced ALDH2 activity.

• APOC1 Drives Papillary Thyroid Carcinoma and Cyclopamine Syn

  2026-06-14

  This study identifies APOC1 as a key driver of papillary thyroid carcinoma (PTC) progression and immune evasion. It demonstrates that targeting APOC1 sensitizes PTC cells to cyclopamine—a Hedgehog pathway inhibitor—suggesting a novel, combinatorial therapeutic strategy for advanced thyroid cancer.

• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-06-13

  This study uncovers how berberine inhibits senescence-associated secretory phenotype (SASP)–mediated inflammation in atherosclerosis through the RXRα/PPARγ/NEDD4 axis. The findings provide mechanistic insight into anti-inflammatory strategies targeting macrophage-driven vascular aging and inform experimental approaches for dissecting the PPARγ signaling pathway.

• PERK-JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration

  2026-06-12

  Chen et al. reveal that endoplasmic reticulum stress triggers pyroptotic death in nucleus pulposus cells via PERK-dependent activation of the JAK1–STAT3 pathway, providing mechanistic insight into intervertebral disc degeneration. This work identifies new intervention points for modulating ER stress-driven inflammation and cell death in degenerative disc disease.

• Phalloidin (B7678): Technical Use Guide for F-Actin Stabiliz

  2026-06-12

  Phalloidin (SKU B7678) addresses the need for high-affinity, species-independent visualization and stabilization of F-actin in fixed and permeabilized biological samples. It is not suitable for live-cell imaging or for workflows requiring reversible actin binding. For robust static cytoskeleton analysis, this reagent ensures reliable preservation and clear visualization of actin structures.

• Acetylcholine Chloride in Gut-Brain Axis Research Workflows

  2026-06-11

  Acetylcholine Chloride enables precision modeling of cholinergic signaling in gut-brain axis studies—now pivotal for dissecting antiseizure mechanisms. This article translates breakthrough findings into actionable workflows and troubleshooting tips for neuroscience and microbiota researchers.

• Septin4 Enhances Hypoxic Cardiomyocyte Injury via HIF-1α Deg

  2026-06-11

  This study reveals that Septin4 exacerbates hypoxia-induced injury in cardiomyocytes by promoting the ubiquitination and degradation of HIF-1α through the VHL pathway. The findings illuminate a novel regulatory axis with implications for understanding myocardial ischemia pathogenesis and potential therapeutic strategies targeting HIF-1α stabilization.

• Cy3-UTP: Precision Fluorescent RNA Labeling for Interaction

  2026-06-10

  Cy3-UTP is a Cy3-modified uridine triphosphate enabling robust, photostable RNA labeling for in vitro transcription. This article details Cy3-UTP's mechanism, benchmarking evidence, and best practices for high-sensitivity RNA-protein interaction studies.

8680 records 9/579 page Previous Next First page 上5页 678910 下5页 Last page